BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuijpers SA, Coimbra MJ, Storm G, Schiffelers RM. Liposomes targeting tumour stromal cells. Mol Membr Biol 2010;27:328-40. [PMID: 20939769 DOI: 10.3109/09687688.2010.522204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Kumar N, Patwal T, Kumar V, Shrivastava P, Mehra A, Maurya PK. Clinical trials in drug delivery for the treatment of cancer. Advanced Drug Delivery Systems in the Management of Cancer 2021. [DOI: 10.1016/b978-0-323-85503-7.00002-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Hua S, de Matos MBC, Metselaar JM, Storm G. Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization. Front Pharmacol 2018;9:790. [PMID: 30065653 DOI: 10.3389/fphar.2018.00790] [Cited by in Crossref: 408] [Cited by in F6Publishing: 433] [Article Influence: 81.6] [Reference Citation Analysis]
3 Mertins O, Dimova R. Insights on the Interactions of Chitosan with Phospholipid Vesicles. Part I: Effect of Polymer Deprotonation. Langmuir 2013;29:14545-51. [DOI: 10.1021/la403218c] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
4 Nehoff H, Taurin S, Greish K. Toxicological Assessment of Nanomedicine. Pharmaceutical Sciences Encyclopedia 2013. [DOI: 10.1002/9780470571224.pse499] [Reference Citation Analysis]
5 Xiao W, Luo J, Jain T, Riggs JW, Tseng HP, Henderson PT, Cherry SR, Rowland D, Lam KS. Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer. Int J Nanomedicine 2012;7:1587-97. [PMID: 22605931 DOI: 10.2147/IJN.S29306] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]